The ATS 2024 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in ILD & IPF, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the conference website. For more information on these and other sessions to be presented May 17–22 in San Diego, visit the online Advance Program.
- A84. Combined Pulmonary Fibrosis and Emphysema: From Pathogenesis to Diagnosis and Therapeutic Implications
- B82. Screening and Early Diagnosis of ILD in Patients with Connective Tissue Disease
- B83. Artificial Intelligence in the Radiological Assessment of Interstitial Lung Disease
- C81. Current and Evolving Strategies for Management of Pulmonary Sarcoidosis
- C82. Pro/Con Debate on Progressive Pulmonary Fibrosis: Improving Understanding of a Disease Phenotype
- C83. Pro/Con: Hot topics in Interstitial Lung Disease
- C85. ATS Documents: Advancing Science and Improving Clinical Practice
- D3. Interstitial Lung Abnormalities: Moving the Needle Towards Therapeutic Clinical Trials
- D4. Lymphangioleiomyomatosis: At the Forefront of Scientific and Clinical Progress
- D6. What Causes Sarcoidosis
- D82. Who, What, Where, Why, How? Inhalational Exposures and ILD
Extend Your Learning Beyond San Francisco with ATS 2025 Conference Highlights
With so many valuable educational opportunities offered during the ATS 2025 International Conference, attendees are often forced to decide which sessions to prioritize. That’s why the Society is offering three ATS 2025 Conference Highlights packages for those unable to attend ATS 2025 San Francisco or attendees interested in continuing their education after the conference. Check out the packages and pick the one that’s right for you. Learn at your own pace, whenever and wherever you are!